Article Details
Retrieved on: 2025-01-31 19:22:44
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the J.P. Morgan Healthcare Conference, highlighting significant mergers and acquisitions in biopharma, including the rise of biotechnology in China, impacting the global industry, and prominent players like AstraZeneca. The conference's focus aligns with key trends in pharmaceuticals and biotechnology.
Article found on: www.morganlewis.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here